FDA approves Iovance Biotherapeutics cell therapy for skin cancer

Iovance Biotherapeutics

16/02/2024 20:35

Feb 16 (Reuters) - Iovance Biotherapeutics  IOVA.O  said
on Friday the U.S. health regulator had granted accelerated
approval for its therapy, the first of its kind, as first
treatment option for adult patients with advanced melanoma, the
deadliest form of skin cancer. 
    

 (Reporting by Pratik Jain in Bengaluru; Editing by Shinjini
Ganguli)
 ((Pratik.Jain@thomsonreuters.com;))